Related Experiment Video
Updated: Jun 5, 2025

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Outcomes of 23-Gauge Pars Plana Vitrectomy in Various Vitreoretinal Diseases
Abdul Hannan1, Fiza Shaheen2,1, Muhammad Saad1
1Ophthalmology, Al-Shifa Trust Eye Hospital, Rawalpindi, PAK.
Abstract:
Background This study aimed to evaluate the safety, efficacy, and complications of 23-gauge (23-G) pars plana vitrectomy (PPV) in the treatment of various vitreoretinal diseases. Methodology A retrospective, cross-sectional study was conducted at Al-Shifa Trust Eye Hospital, Rawalpindi. All the eyes undergoing 23-G PPV between June 2020 and May 2023 meeting the inclusion criteria were included. Surgical outcomes and complications were assessed. Results A total of 350 eyes were included in our data. The most common indication was rhegmatogenous retinal detachment (RRD) (n = 144, 41.1%), followed by diabetic tractional retinal detachment (TRD) (n = 98, 21%). Satisfactory anatomical outcomes were achieved in all the indications. The primary success rate was 87.5% for RRD and 96.9% for TRD. The overall complication rate was 17.7%, with postoperative cataracts being the most frequent. Conclusions The 23-G PPV technique has proven to be a safe and effective approach for the surgical management of various vitreoretinal diseases, demonstrating favorable anatomical outcomes and a low rate of complications.
More Related Videos
Related Concept Videos
Glaucoma: Overview
Angle Closure Glaucoma: Treatment

